Increased visceral fat tissue appears to be associated with metabolic disorders. Other factors related to the individual’s health and specifically to HIV may also play a role in the development of ...

Rosiglitazone and metformin had differing modest effects on fat and plasma lipid parameters associated with HIV lipodystrophy. Metformin and rosiglitazone have both been evaluated for the ...

NEW YORK, 26 July (Praxis Press) The human immunodeficiency virus (HIV) lipodystrophy syndrome is characterized by fat redistribution and insulin resistance; this syndrome is particularly common among ...

for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy. Each single-patient-use vial of Egrifta WR contains tesamorelin 11.6mg (equivalent to approximately 11 ...

Mondy and colleagues [50] reported the preliminary results of a study that characterized osteopenia by performing transiliac biopsies after tetracycline labeling in 7 HIV-infected men ...

HIV-associated lipodystrophy can occur as a side effect of antiretroviral treatment. Symptoms of lipodystrophy include fat loss in areas like the face, arms, legs, and buttocks, abnormal fat ...

Tesamorelin for injection is the only medication approved in the U.S. for the reduction of excess abdominal fat in adults with HIV who have lipodystrophy. The new formulation, EGRIFTA WR™, is a ...